These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 33392498)

  • 41. Enhanced Solubility and Bioavailability of Dolutegravir by Solid Dispersion Method: In Vitro and In Vivo Evaluation-a Potential Approach for HIV Therapy.
    Chaudhary S; Nair AB; Shah J; Gorain B; Jacob S; Shah H; Patel V
    AAPS PharmSciTech; 2021 Apr; 22(3):127. PubMed ID: 33835317
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of Polymer Permeability and Solvent Removal Rate on
    Zhang X; Yang L; Zhang C; Liu D; Meng S; Zhang W; Meng S
    Pharmaceutics; 2019 Oct; 11(10):. PubMed ID: 31658642
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Feasibility of poly (ϵ-caprolactone-co-DL-lactide) as a biodegradable material for in situ forming implants: evaluation of drug release and in vivo degradation.
    Zhang X; Zhang C; Zhang W; Meng S; Liu D; Wang P; Guo J; Li J; Guan Y; Yang D
    Drug Dev Ind Pharm; 2015 Feb; 41(2):342-52. PubMed ID: 24320881
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of PLGA End Groups on the Release Profile of Dexamethasone from Ocular Implants.
    Saraf I; Kushwah V; Alva C; Koutsamanis I; Rattenberger J; Schroettner H; Mayrhofer C; Modhave D; Braun M; Werner B; Zangger K; Paudel A
    Mol Pharm; 2023 Feb; 20(2):1307-1322. PubMed ID: 36680524
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of polymer type on the dynamics of phase inversion and drug release in injectable in situ gelling systems.
    Liu H; Venkatraman SS
    J Biomater Sci Polym Ed; 2012; 23(1-4):251-66. PubMed ID: 21244721
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Novel adapter method for in vitro release testing of in situ forming implants.
    Wang X; Bao Q; Suh MS; Kastellorizios M; Wang R; Burgess DJ
    Int J Pharm; 2022 Jun; 621():121777. PubMed ID: 35489601
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Design of a long-term antipsychotic in situ forming implant and its release control method and mechanism.
    Wang L; Wang A; Zhao X; Liu X; Wang D; Sun F; Li Y
    Int J Pharm; 2012 May; 427(2):284-92. PubMed ID: 22387369
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reverse engineering the Ozurdex dexamethasone intravitreal implant.
    Costello MA; Liu J; Wang Y; Qin B; Xu X; Li Q; Lynd NA; Zhang F
    Int J Pharm; 2023 Mar; 634():122625. PubMed ID: 36690129
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug-Eluting Biodegradable Implants for the Sustained Release of
    Dharmayanti C; Gillam TA; Williams DB; Blencowe A
    Polymers (Basel); 2020 Dec; 12(12):. PubMed ID: 33297466
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
    Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
    Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Drug delivery from hydroxyapatite-coated titanium surfaces using biodegradable particle carriers.
    Son JS; Choi YA; Park EK; Kwon TY; Kim KH; Lee KB
    J Biomed Mater Res B Appl Biomater; 2013 Feb; 101(2):247-57. PubMed ID: 23143817
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Encapsulation of Nicardipine Hydrochloride and Release from Biodegradable Poly(D,L-lactic-co-glycolic acid) Microparticles by Double Emulsion Process: Effect of Emulsion Stability and Different Parameters on Drug Entrapment.
    Soomherun N; Kreua-Ongarjnukool N; Chumnanvej S; Thumsing S
    Int J Biomater; 2017; 2017():1743765. PubMed ID: 29250113
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An Accelerated Release Study to Evaluate Long-Acting Contraceptive Levonorgestrel-Containing in Situ Forming Depot Systems.
    Janagam DR; Wang L; Ananthula S; Johnson JR; Lowe TL
    Pharmaceutics; 2016 Sep; 8(3):. PubMed ID: 27598191
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of the microencapsulation method and peptide loading on poly(lactic acid) and poly(lactic-co-glycolic acid) degradation during in vitro testing.
    Witschi C; Doelker E
    J Control Release; 1998 Feb; 51(2-3):327-41. PubMed ID: 9685930
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of solvent used for fabrication on drug loading and release kinetics of electrosprayed temozolomide-loaded PLGA microparticles for the treatment of glioblastoma.
    Rodriguez de Anda DA; Ohannesian N; Martirosyan KS; Chew SA
    J Biomed Mater Res B Appl Biomater; 2019 Oct; 107(7):2317-2324. PubMed ID: 30767394
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In situ forming implants for the delivery of metronidazole to periodontal pockets: formulation and drug release studies.
    Kilicarslan M; Koerber M; Bodmeier R
    Drug Dev Ind Pharm; 2014 May; 40(5):619-24. PubMed ID: 24369747
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Injectable, in situ forming poly(propylene fumarate)-based ocular drug delivery systems.
    Ueda H; Hacker MC; Haesslein A; Jo S; Ammon DM; Borazjani RN; Kunzler JF; Salamone JC; Mikos AG
    J Biomed Mater Res A; 2007 Dec; 83(3):656-66. PubMed ID: 17514745
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Brush-like branched biodegradable polyesters, part III. Protein release from microspheres of poly(vinyl alcohol)-graft-poly(D,L-lactic-co-glycolic acid).
    Frauke Pistel K; Breitenbach A; Zange-Volland R; Kissel T
    J Control Release; 2001 May; 73(1):7-20. PubMed ID: 11337055
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Controlled release of NFkappaB decoy oligonucleotides from biodegradable polymer microparticles.
    Zhu X; Lu L; Currier BL; Windebank AJ; Yaszemski MJ
    Biomaterials; 2002 Jul; 23(13):2683-92. PubMed ID: 12059017
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of injection site on in situ implant formation and drug release in vivo.
    Patel RB; Solorio L; Wu H; Krupka T; Exner AA
    J Control Release; 2010 Nov; 147(3):350-8. PubMed ID: 20728486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.